Integrated bioinformatic analysis for the identification of potential biomarkers of kidney damage in hyperoxaluria

Usha Adiga; Shreyas Adiga; Thayyil Menambath Desy; Neha Honnalli; Tirthal Rai

doi:10.7324/JAPS.2023.137646

Abstract

Hyperoxaluria is described by an augmented urinary elimination of oxalate. Systemic oxalosis is the term for the condition that occurs when the burden of calcium oxalate (CaOx) surpasses the renal capacity to excrete it. When individuals acquire chronic renal disease, elevated urinary oxalate levels aid in diagnosis, whereas plasma oxalate levels are probably more reliable. Based on bioinformatic analysis, the study aimed to identify differentially expressed genes (DEGs) and miRNA as potential biomarkers to differentiate normal versus hyperoxaluric states compared to the stage of CaOx crystals in the kidney. Published microarray data for gene expression patterns of normal controls, hyperoxaluric kidney tissue, and kidney tissue at the stage of crystal formation were collected from the National Center for Biotechnology Information Gene Expression Omnibus database. Integrated bioinformatics methods were utilized to analyze and compare these gene expression patterns. The data processing was conducted using R software. Gene ontology and the Kyoto Encyclopedia of Genes and Genomes database were employed to explore the enrichment of pathways and functions in the DEGs. Additionally, the STRING database was utilized to investigate protein–protein interactions. Tarbase, Mirnda, and DIANA software were used to obtain miRNAs for the top 10 DEGs. A total of 62,966 genes were screened, 2,814 were differentially expressed, out of which 603 genes were statistically significantly differentially expressed, after analyzing the GSE89028 dataset. A total of 2,810 genes were downregulated and only 4 genes were upregulated on day 14. The genes Cdt1 and cdhr4 were highly significantly differentiated with log2 (fold change) being −3.085 and −3.966, respectively, −log 10 (p-value) being 6.857 and 6.196, respectively, at 14 days. On day 28, 62,976 genes were screened, out of which 356 were significantly differentiated. Only four genes were upregulated and 240 genes were downregulated. Csmd1, Olr154, Cntfr, Zbtb16 log2 (fold change) being 1.188, 1.527, 1.782, and 2.636, respectively; −log 10 (p-value) being 4.071, 3.804, 4.357, and 4.061, respectively. The text mining evidence was observed on string analysis in both contexts. The strength of alternative splicing (cellular enrichment) was 1.16 with a false discovery rate of 0.0409. The study showcases the effectiveness of bioinformatics analytical methods in pinpointing potential pathogenic genes associated with hyperoxaluria and the deposition of crystals in the kidneys. The interaction network identified two miRNAs, hsa-miR-6884-5p and hsa-miR-4653-5p, and two genes CDHR4 and EGR2 as significant players.

Keyword: Hyperoxaluria calcium oxalate crystals kidney damage bioinformatics prediction of markers

Citation:

Adiga U, Adiga S, Desy TM, Honnalli N, Rai T. Integrated bioinformatic analysis for the identification of potential biomarkers of kidney damage in hyperoxaluria. J Appl Pharm Sci. 2023. Online First. http://doi.org/10.7324/JAPS.2023.137646

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reference

1. Asplin JR. Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am. 2002;31:927-49. https://doi.org/10.1016/S0889-8529(02)00030-0

2. Milliner DS. The primary hyperoxalurias: an algorithm for diagnosis. Am J Nephrol. 2005;25:154-60. https://doi.org/10.1159/000085407

3. Robijn S, Hoppe B, Vervaet BA, D'Haese PC, Verhulst A. Hyperoxaluria: a gut-kidney axis? Kidney Int. 2011;80:1146-58. https://doi.org/10.1038/ki.2011.287

4. Arena R, Cahalin LP. Evaluation of cardiorespiratory fitness and respiratory muscle function in the obese population. Prog Cardiovasc Dis. 2014;56:457-64. https://doi.org/10.1016/j.pcad.2013.08.001

5. Hoppe B, Langman CB. A United States survey on diagnosis, treatment, and outcome of primary hyperoxaluria. Pediatr Nephrol. 2003;18:986-91. https://doi.org/10.1007/s00467-003-1234-x

6. Spasovski G, Beck BB, Blau N, Hoppe B, Tasic V. Late diagnosis of primary hyperoxaluria after failed kidney transplantation. Int Urol Nephrol. 2010;42:825-29. https://doi.org/10.1007/s11255-009-9690-2

7. Joshi S, Wang W, Khan SR. Transcriptional study of hyperoxaluria and calcium oxalate nephrolithiasis in male rats: inflammatory changes are mainly associated with crystal deposition. PLoS One. 2017;12(11):e0185009. https://doi.org/10.1371/journal.pone.0185009

8. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504-7. https://doi.org/10.1038/nature12060

9. Guzman MG, Harris E. Dengue. Lancet. 2015;385(9966):453-65. https://doi.org/10.1016/S0140-6736(14)60572-9

10. Shahen M, Guo Z, Shar AH, Ebaid R, Tao Q, Zhang W, et al. Dengue virus causes changes of MicroRNA-genes regulatory network revealing potential targets for antiviral drugs. BMC Syst Biol. 2018;12(1):2. https://doi.org/10.1186/s12918-017-0518-x

11. Tsai CY, Lee IK, Lee CH, Yang KD, Liu JW. Comparisons of dengue illness classified based on the 1997 and 2009 World Health Organization dengue classification schemes. J Microbiol Immunol Infect. 2013;46(4):271-81. https://doi.org/10.1016/j.jmii.2012.07.005

12. Castro MC, Wilson ME, Bloom DE. Disease and economic burdens of dengue. Lancet Infect Dis. 2017;17(3):e70-e8. 13. Pei H, Zuo L, Ma J, Cui L, Yu F, Lin Y. Transcriptome profiling reveals differential expression of interferon family induced by dengue virus 2 in human endothelial cells on tissue culture plastic and polyacrylamide hydrogel. J Med Virol. 2016;88(7):1137-51. https://doi.org/10.1002/jmv.24465

14. Biswal S, Reynales H, Saez-Llorens X, Lopez P, Borja-Tabora C, Kosalaraksa P, et al. Efficacy of a tetravalent dengue vaccine in healthy children and adolescents. N Engl J Med. 2019;381(21):2009-19. https://doi.org/10.1056/NEJMoa1903869

15. Moodie Z, Juraska M, Huang Y, Zhuang Y, Fong Y, Carpp LN, et al. Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America. J Infect Dis. 2018;217(5):742-53. https://doi.org/10.1093/infdis/jix609

16. Chou CH, Shrestha S, Yang CD, Chang NW, Lin YL, Liao KW, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296-302.

17. Pu M, Chen J, Tao Z, Miao L, Qi X, Wang Y, et al. Regulatory network of miRNA on its target: coordination between transcriptional and post-transcriptional regulation of gene expression. Cell Mol Life Sci. 2019;76(3):441-51. https://doi.org/10.1007/s00018-018-2940-7

18. Ryan MM, Lockstone HE, Huffaker SJ, Wayland MT, Webster MJ, Bahn S. Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry. 2006;11:965-78. https://doi.org/10.1038/sj.mp.4001875

19. Clifton NE, Hannon E, Harwood JC, Di Florio A, Thomas KL, Holmans PA, et al. Dynamic expression of genes associated with schizophrenia and bipolar disorder across development. Transl Psychiatry. 2019;9(1):74. https://doi.org/10.1038/s41398-019-0405-x

20. Kumar A, Pareek V, Singh HN, Faiq MA, Narayan RK, Raza K, Kumar P. Altered expression of a unique set of genes reveals complex etiology of schizophrenia. Front Psychiatry. 2019;10:906. https://doi.org/10.3389/fpsyt.2019.00906

21. Panizo S, Martínez-Arias L, Alonso-Montes C, Cannata P, Martín-Carro B, Fernández-Martín JL, et al. Fibrosis in chronic kidney disease: pathogenesis and consequences. Int J Mol Sci. 2021;22(1):408. doi: https://doi.org/10.3390/ijms22010408 https://doi.org/10.3390/ijms22010408

22. Carbonell T, Gomes AV. MicroRNAs in the regulation of cellular redox status and its implications in myocardial ischemia-reperfusion injury. Redox Biol. 2020;36:101607. https://doi.org/10.1016/j.redox.2020.101607

23. Peters LJF, Floege J, Biessen EAL, Jankowski J, van der Vorst EPC. MicroRNAs in chronic kidney disease: four candidates for clinical application. Int J Mol Sci. 2020 https://doi.org/10.3390/ijms21186547

21(18):6547. doi: https://doi.org/10.3390/ijms21186547 24. Jiang K, Hu J, Luo G, Song D, Zhang P, Zhu J, et al. miR-155-5p promotes oxalate- and calcium-induced kidney oxidative stress injury by suppressing MGP expression. Oxid Med Cell Longev. 2020 Mar 4;2020:5863617.

25. Wang B, He G, Xu G, Wen J, Yu X. miRNA-34a inhibits cell adhesion by targeting CD44 in human renal epithelial cells: implications for renal stone disease. Urolithiasis. 2019;48(2):109-16. doi: https://doi.org/10.1007/s00240-019-01155-9 https://doi.org/10.1007/s00240-019-01155-9

26. Shi J, Duan J, Gong H, Pang Y, Wang L, Yan Y. Exosomes from miR-20b-3p-overexpressing stromal cells ameliorate calcium oxalate deposition in rat kidney. J Cell Mol Med. 2019;23(11):7268-78. https://doi.org/10.1111/jcmm.14555

27. Liu H, Ye T, Yang X, Liu J, Jiang K, Lu H, et al. H19 promote calcium oxalate nephrocalcinosis-induced renal tubular epithelial cell injury via a ceRNA pathway. eBioMedicine. 2019;50:366-78. doi: https://doi.org/10.1016/j.ebiom.2019.10.059 https://doi.org/10.1016/j.ebiom.2019.10.059

28. Chen Z, Yuan P, Sun X, Tang K, Liu H, Han S, et al. Pioglitazone decreased renal calcium oxalate crystal formation by suppressing M1 macrophage polarization via the PPAR-gamma-miR-23 axis. Am J Physiol Renal Physiol. 2019;317(1):F137-51. https://doi.org/10.1152/ajprenal.00047.2019

29. Liang X, Lai Y, Wu W, Chen D, Zhong F, Huang J, et al. LncRNA-miRNA-mRNA expression variation profile in the urine of calcium oxalate stone patients. BMC Med Genomics. 2019;12(1):57. https://doi.org/10.1186/s12920-019-0502-y

Abstract

HTML Full Text

Reference

Article Metrics

Related Search

Citiaion Alert By Google Scholar

Similar Articles